Brought to you by 
Beckman Coulter sells 4.5mm shares
05 Aug 2009
Executive Summary
Beckman Coulter netted $228mm through the follow-on public offering of 4.5mm common shares at $53. Proceeds from this offering, along with a concurrent sale of $500mm of the company's senior notes, will be used to fund Beckman's $800mm acquisition of Olympus Corp.'s diagnostic systems business that was announced in February of this year.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Hematology, Coagulation
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Beckman Coulter sells 4.5mm shares
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice